| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.061 | 0.4 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.4 |